PL353244A1 - Sposób terapeutycznego postępowania z pozamaciczną proliferacją tkanki śluzówki macicy, przewlekłymbólem miednicy i zaczopowaniem jajowodu - Google Patents

Sposób terapeutycznego postępowania z pozamaciczną proliferacją tkanki śluzówki macicy, przewlekłymbólem miednicy i zaczopowaniem jajowodu

Info

Publication number
PL353244A1
PL353244A1 PL00353244A PL35324400A PL353244A1 PL 353244 A1 PL353244 A1 PL 353244A1 PL 00353244 A PL00353244 A PL 00353244A PL 35324400 A PL35324400 A PL 35324400A PL 353244 A1 PL353244 A1 PL 353244A1
Authority
PL
Poland
Prior art keywords
fallopian tube
pelvic pain
chronic pelvic
endometrial tissue
therapeutic management
Prior art date
Application number
PL00353244A
Other languages
English (en)
Other versions
PL201898B1 (pl
Inventor
Jurgen Engel
Hilde Riethmuller-Winzen
Ricardo Felberbaum
Klaus Diedrich
Wolfgang Kupker
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of PL353244A1 publication Critical patent/PL353244A1/pl
Publication of PL201898B1 publication Critical patent/PL201898B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL353244A 1999-09-23 2000-09-20 Zastosowanie antagonisty LH-RH w leczeniu endometriozy PL201898B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15547899P 1999-09-23 1999-09-23
PCT/EP2000/009212 WO2001021194A2 (en) 1999-09-23 2000-09-20 Method for the therapeutic management of endometriosis and fallopian tube obstruction

Publications (2)

Publication Number Publication Date
PL353244A1 true PL353244A1 (pl) 2003-11-03
PL201898B1 PL201898B1 (pl) 2009-05-29

Family

ID=22555601

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353244A PL201898B1 (pl) 1999-09-23 2000-09-20 Zastosowanie antagonisty LH-RH w leczeniu endometriozy

Country Status (22)

Country Link
EP (1) EP1214086A2 (pl)
JP (2) JP2003509467A (pl)
KR (1) KR100772852B1 (pl)
CN (2) CN1376070A (pl)
AU (1) AU769482B2 (pl)
BG (1) BG66128B1 (pl)
BR (1) BR0014198A (pl)
CA (1) CA2383510A1 (pl)
HK (1) HK1049117A1 (pl)
HU (1) HUP0202741A3 (pl)
IL (1) IL148185A0 (pl)
MX (1) MXPA02002436A (pl)
NO (1) NO331198B1 (pl)
NZ (1) NZ534836A (pl)
PL (1) PL201898B1 (pl)
RU (1) RU2255759C2 (pl)
SK (1) SK3752002A3 (pl)
TR (1) TR200200738T2 (pl)
TW (1) TWI267373B (pl)
UA (1) UA73956C2 (pl)
WO (1) WO2001021194A2 (pl)
ZA (1) ZA200201374B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10157628A1 (de) * 2001-11-26 2003-06-12 Zentaris Ag Injektionslösung eines LHRH-Antagonisten
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
DK2252627T3 (en) 2008-01-24 2017-08-14 Esperance Pharmaceuticals MERGER CONSTRUCTION WITH LYTIC DOMAIN AND METHOD FOR PRODUCING AND USING SAME.
US20120053122A1 (en) * 2009-01-22 2012-03-01 Maatschap Interne Geneeskunde Rijnstate Method for the prophylaxis or treatment of flushing
US9492563B2 (en) 2012-10-30 2016-11-15 Esperance Pharmaceuticals, Inc. Antibody/drug conjugates and methods of use
EP3384930A1 (en) 2013-03-15 2018-10-10 AbbVie Inc. Compositions for use in treating heavy menstrual bleeding
US12083227B2 (en) 2017-08-18 2024-09-10 Abbvie Inc. Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
EA202090461A1 (ru) 2017-08-18 2020-06-29 Эббви Инк. Фармацевтические препараты для лечения эндометриоза, миомы матки, синдрома поликистоза яичников или аденомиоза
CN112261942A (zh) 2018-04-19 2021-01-22 艾伯维公司 治疗重度月经出血的方法
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
SE9301606D0 (sv) * 1993-05-07 1993-05-07 Per-Christer Oden Composition for the treatment of impaired hair growth
US5658884A (en) * 1994-07-22 1997-08-19 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
MX9700574A (es) * 1994-07-22 1997-12-31 Hampton Roads Medical College Metodo para establecer la secrecion de estrogeno tonico ovarico para regimenes terapeuticos prolongados.
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19604231A1 (de) * 1996-01-29 1997-07-31 Schering Ag Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
RU2108583C1 (ru) * 1996-07-29 1998-04-10 Николай Владимирович Рымашевский Способ определения показаний к проведению гормонотерапии у больных генитальным эндометриозом
CN1228708A (zh) * 1996-09-04 1999-09-15 有限会社多特 经口给药用含肽药物组合物
JP2002502426A (ja) * 1997-06-05 2002-01-22 メルク エンド カンパニー インコーポレーテッド ゴナドトロピン放出ホルモンの拮抗薬
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
CN101045155A (zh) 2007-10-03
JP2012051920A (ja) 2012-03-15
MXPA02002436A (es) 2003-02-12
EP1214086A2 (en) 2002-06-19
JP2003509467A (ja) 2003-03-11
WO2001021194A3 (en) 2002-03-14
NZ534836A (en) 2007-07-27
KR100772852B1 (ko) 2007-11-02
HK1049117A1 (zh) 2003-05-02
BG66128B1 (bg) 2011-06-30
BG106584A (bg) 2003-02-28
AU7779200A (en) 2001-04-24
NO20021430D0 (no) 2002-03-21
TR200200738T2 (tr) 2002-08-21
AU769482B2 (en) 2004-01-29
BR0014198A (pt) 2002-05-21
IL148185A0 (en) 2002-09-12
TWI267373B (en) 2006-12-01
ZA200201374B (en) 2002-10-30
HUP0202741A2 (hu) 2003-01-28
WO2001021194A2 (en) 2001-03-29
CA2383510A1 (en) 2001-03-29
NO20021430L (no) 2002-05-07
UA73956C2 (en) 2005-10-17
RU2255759C2 (ru) 2005-07-10
HUP0202741A3 (en) 2003-12-29
SK3752002A3 (en) 2003-06-03
NO331198B1 (no) 2011-10-31
PL201898B1 (pl) 2009-05-29
CN1376070A (zh) 2002-10-23
KR20020035879A (ko) 2002-05-15

Similar Documents

Publication Publication Date Title
AU3734300A (en) Method and apparatus for establishing and maintaining therapeutic hypothermia
IL132760A0 (en) Vibrator for treatment of constipation
AU7842500A (en) System for orthopedic treatment
EP1404343A4 (en) THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
MY145215A (en) Vaginalli administered anti-dysrhythmic agents for treating uterine dysrhythmia
AU2317600A (en) Pressure-pulse therapy apparatus for treatment of tissue
IL148185A0 (en) Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
HUP0204448A3 (en) Trnasdermal therapeutic system for the delivery of lerisetron
IL130171A0 (en) Therapeutic use of melatonin
IL148166A0 (en) Drug for treating fractures
GB0031654D0 (en) Apparatus for the diagnosis and therapy of neuro-muscular and other tissue disorders
EP1171579A4 (en) TR9 HUMAN RECEPTOR OF TUMOR NECROSIS FACTORS
EP1210370A4 (en) TUMOR NECROSIS FACTOR TR16 HUMAN RECEPTOR
GB9911238D0 (en) Therapeutic use
HUP0402664A3 (en) 2-indanylamino derivatives for the therapy of chronic pain
TW422099U (en) Spinal massage device
NZ514013A (en) Treatment of hiatial hernia
GB9912184D0 (en) Therapeutic use
GB9913350D0 (en) Therapeutic use
GB9921953D0 (en) Therapeutic use
GB9924980D0 (en) Therapeutic treatment

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20120920